Drug Recalls and Withdrawals
Drug Recalls and Withdrawals
For a full list of all current Class 1 drug recalls and withdrawals, please see below:
For a full list of all current Class 1 drug recalls and withdrawals, please see below:
Amneal announced a voluntary, consumer level recall of three lots of sulfamethoxazole/trimethoprim tablets because the tablets may exhibit black spots on the tablet surface due to microbial contamination. For more information, please click here.
Alvogen announced a voluntary, consumer level recall of one lot of fentanyl transdermal system 25 mcg/h transdermal patches because there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
For more information, please click here.
Endo announced a consumer level recall of one lot of clonazepam orally disintegrating 0.25 mg tablets because they may have been packaged in a carton labelled as 0.125 mg. For more information, please click here.
Glenmark announced a consumer level recall of 114 lots of potassium chloride extended-release capsules because they may not dissolve correctly which may lead to hyperkalemia. On 08/09/2024, WHA was notified by OptumRx that the recall classification type had been updated to class 1. For more information, please click here.
2349 Gateway Oaks Drive, Suite 100
Sacramento, California 95833